KBC Group NV Sells 893 Shares of AptarGroup, Inc. $ATR

KBC Group NV lowered its holdings in shares of AptarGroup, Inc. (NYSE:ATR) by 35.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,646 shares of the industrial products company’s stock after selling 893 shares during the period. KBC Group NV’s holdings in AptarGroup were worth $257,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the business. Mawer Investment Management Ltd. grew its stake in shares of AptarGroup by 16.4% during the second quarter. Mawer Investment Management Ltd. now owns 1,400,757 shares of the industrial products company’s stock valued at $219,120,000 after buying an additional 197,214 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in AptarGroup by 12.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 800,182 shares of the industrial products company’s stock valued at $118,723,000 after acquiring an additional 87,719 shares during the period. Fiduciary Management Inc. WI grew its position in AptarGroup by 40.8% during the 1st quarter. Fiduciary Management Inc. WI now owns 767,636 shares of the industrial products company’s stock worth $113,902,000 after acquiring an additional 222,577 shares during the last quarter. Federated Hermes Inc. increased its stake in AptarGroup by 4.8% in the 1st quarter. Federated Hermes Inc. now owns 756,352 shares of the industrial products company’s stock worth $112,228,000 after purchasing an additional 34,567 shares during the period. Finally, Acadian Asset Management LLC lifted its position in AptarGroup by 1.0% in the second quarter. Acadian Asset Management LLC now owns 487,782 shares of the industrial products company’s stock valued at $76,290,000 after purchasing an additional 4,845 shares during the last quarter. 88.52% of the stock is owned by institutional investors.

Insider Activity at AptarGroup

In related news, insider Shiela Vinczeller sold 1,167 shares of AptarGroup stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $137.97, for a total transaction of $161,010.99. Following the sale, the insider directly owned 25,134 shares in the company, valued at $3,467,737.98. The trade was a 4.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gael Touya sold 2,500 shares of the stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $136.12, for a total value of $340,300.00. Following the completion of the transaction, the insider owned 31,463 shares of the company’s stock, valued at approximately $4,282,743.56. This trade represents a 7.36% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.68% of the company’s stock.

AptarGroup Trading Down 0.0%

NYSE:ATR opened at $119.31 on Wednesday. The company has a 50-day moving average price of $127.73 and a 200-day moving average price of $142.62. The stock has a market cap of $7.83 billion, a price-to-earnings ratio of 20.53, a P/E/G ratio of 2.55 and a beta of 0.55. The company has a current ratio of 1.21, a quick ratio of 0.83 and a debt-to-equity ratio of 0.20. AptarGroup, Inc. has a 12 month low of $103.23 and a 12 month high of $174.10.

AptarGroup (NYSE:ATR) last announced its quarterly earnings results on Thursday, October 30th. The industrial products company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.05. AptarGroup had a net margin of 10.84% and a return on equity of 15.39%. The company had revenue of $961.13 million for the quarter, compared to analysts’ expectations of $950.55 million. During the same quarter in the previous year, the company earned $1.49 earnings per share. AptarGroup’s quarterly revenue was up 5.7% on a year-over-year basis. AptarGroup has set its Q4 2025 guidance at 1.200-1.28 EPS. Equities analysts predict that AptarGroup, Inc. will post 5.57 EPS for the current year.

AptarGroup Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, November 13th. Stockholders of record on Thursday, October 23rd were paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date was Thursday, October 23rd. This is a boost from AptarGroup’s previous quarterly dividend of $0.45. AptarGroup’s dividend payout ratio (DPR) is 30.72%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. William Blair cut shares of AptarGroup from an “outperform” rating to a “market perform” rating in a report on Monday, November 3rd. Weiss Ratings restated a “hold (c)” rating on shares of AptarGroup in a research report on Thursday, November 13th. Raymond James Financial reaffirmed an “outperform” rating and set a $172.00 price objective (down from $182.00) on shares of AptarGroup in a research note on Monday, August 4th. Wells Fargo & Company cut their target price on AptarGroup from $152.00 to $133.00 and set an “overweight” rating on the stock in a research note on Monday, November 3rd. Finally, Zacks Research downgraded AptarGroup from a “hold” rating to a “strong sell” rating in a report on Friday, November 14th. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $168.60.

AptarGroup Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.